InnoCare

Investor Relations

InnoCare is biopharmaceutical company committed to discovering, developing and commercializing potential best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. We have built a fully integrated platform that covers the entire spectrum of drug discovery and development functionalities, including drug target identification and verification, preclinical evaluation, clinical trial design and execution, drug manufacturing and quality control, and commercialization. Our team has discovered and developed a pipeline of nine drug candidates, including one candidate in registrational trials, two candidates under clinical evaluation in Phase I/II trials and six candidates at the IND-enabling stage.